Keywords: LID; lidocaine; LID-B; lidocaine base form; LID-HCl; lidocaine hydrochloride; LLC; lyotropic liquid crystal; NLC; nanostructured lipid carrier; SC; stratum corneum; Lidocaine; Dermal delivery; Skin penetration; Raman spectroscopy; Nanostructured lipid car
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Harsh environments; Nanosilver; Sintered; Lid; Stress;
Keywords: A/O; anoxic/oxic process; AHA; anaerobic hydrolysis and acidification; AOPs; advanced oxidation process; BOD5; 5 d biochemical oxygen demand; CMA; China Metrology Accreditation; CO; catalytic ozonation; COD; chemical oxygen demand; DO; dissolved oxygen; D
Keywords: Dyskinesia; Parkinson's disease; Levodopa; Nitric oxide; NOS1 gene; LID; Levodopa-induced dyskinesia; PD; Parkinson's disease; MDS-UPDRS; International Parkinson and Movement Disorders Society - Unified Parkinson's Disease Rating Scale; SNP; single nucleo
Keywords: GHR; growth hormone receptor; GHRtm; recombinant fragment GHR254-294; JAK2; Janus kinase 2; RTK; receptor tyrosine kinase; TMD; transmembrane domain; ECD; extracellular domain; ICD; intracellular domain; JM; juxtamembrane; ecJM; extracellular juxtamembr
Keywords: Stormwater management; Low impact development; LID; SuDS; LIUDD; WSUD; Green infrastructure; Sustainability; LID implementation; Multi-objective optimization (MOO);
Keywords: Stormwater; Storm sewer; Runoff control; Peak flow rate; Integrated design; IDF; rainfall intensity-duration-frequency; LID; low impact development, also representing onsite runoff control in this work; MOHURD; Ministry of Housing and Urban-Rural Developm
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4- isoxazole propionic acid; ASI; Axon-spine interface; Ca2+; calcium; CNS; Central nervous system; CS-EP; Corticostriatal-evoked potential; DBS; deep brain stimulation; DA; Dopamine; DARPP-32; dopamine-regulated neuronal
Keywords: AC; adenylate cyclase; ADHD; attention deficit hyperactivity disorder; ACC; anterior cingulate cortex; ALS; amyotrophic lateral sclerosis; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ATP; adenosine triphosphate; BBB; blood-brain barrier;
Keywords: DDS; dopamine dysregulation syndrome; PD; Parkinson's disease; NAc; nucleus accumbens; LID; levodopa induced dyskinesia; CPu; caudate and putamen; MSNs; medium spiny neurons; MFB; medial forebrain bundle; 6-OHDA; 6-hydroxydopamine; AIM; abnormal involunta
Keywords: 6-OHDA; 6-hydroxydopamine; ABC; avidin-biotin-peroxidase complex; AIM; abnormal involuntary movement; DDS; dopamine dysregulation syndrome; IT; intratelencephalic; LID; levodopa-induced dyskinesia; PD; Parkinson's disease; PT; pyramidal tract; Dendritic
Keywords: LID; CID; multi-crystalline silicon; dark anneal; defect precursors;
Keywords: Stormwater management; LID; DCIA; Hydrological responses; SWMM; GIS;
Keywords: a-Si; Amorphous-Silicon; BOS; Balance-of-system; CIEMAT; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Spain; FSEC; Florida Solar Energy Center, USA; IAP; Inverter-to-Array Power; IFC; International Finance Corporation; IEA; In
Keywords: 3-HK; 3-hydroxykynurenine; 6-OHDA; 6-hydroxydopamine; A; Amygdala; ACMSD; 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase; AD; Alzheimer's disease; AD; Anterodorsal nucleus (Thalamus); α-syn; Alpha-synuclein; CCL2; Chemokine (CC motif) ligand 2;
Keywords: BP; bitopic protein; RTK; receptor tyrosine kinase; TMD; transmembrane domain; JM; juxtamembrane; ECD; extracellular domain; ICD; intracellular domain; NMR; nuclear magnetic resonance; MD; molecular dynamics; LID; “ligand-induced dimerization” mechani
Keywords: BBB; blood brain barrier; 6-OHDA; 6-hydroxydopamine; PD; Parkinson's disease; H215O; 15O-water; FDG; 18F-fluorodeoxyglucose; CBF; cerebral blood flow; CMR; cerebral metabolic rate for glucose; GP; globus pallidus; LID; levodopa-induced dyskinesia; VOI; vo
Keywords: Decision-making tool; Rainwater management; Stormwater runoff; LID; Integrated design; Bioretention;
Keywords: Allergy; Drug reactions; Steven-Johnson syndrome; Toxic epidermal necrolysis; AA-cADR; Antibiotic-associated cutaneous adverse drug reactions; AGEP; Acute generalized exanthematous pustulosis; BSA; Body surface area; cADR; Cutaneous adverse drug reaction;
Keywords: LID; boron oxygen defects; parameterization; lifetime limitation; Czochralski silicon;
Keywords: LID; DNN; Bottleneck; i-vectors;
Keywords: Anosognosia; Self-awareness; Parkinson's disease; Dyskinesia; Neurodegenerative disorder; BDI-2; Beck-Depression-Inventory 2; DRT; dopamine replacement therapy; FDG; 18F-2fluoro-2-deoxy-d-glucose; FWE; family-wise error; IFG; inferior frontal gyrus; ISA;
Keywords: Green roof; Hydrologic performance; LID; Permeable pavement SWMM; Storm water;
Keywords: ANOVA; analysis of variance; ANCOVA; analysis of covariance; BRC; bioretention cell; CR; runoff coefficient; CWA; clean water act; DCIA; directly connected impervious area; IC; impervious cover; LID; low impact development; QP; peak discharge; ROD; runoff
Keywords: DA; dopamine; DHA; docosahexaenoic acid; l-DOPA; levodopa; LID; l-DOPA-induced-dyskinesias; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MRM; Multiple reaction monitoring; PD; Parkinson's disease; Pls; Plasmalogen; PlsEtn; Ethanolamine plasmalogens
Keywords: LID; light-induced degradation; SWE; Staebler-Wronski effect; SUPSI-ISSAC; Scuola Universitaria Professionale della Svizzera Italiana-Istituto di Sostenibilità Applicata all'Ambiente Costruito; PVUSA; Test Facility Photovoltaics for Utility Scale A
Keywords: 5-HIAA; 5-hydroxyindolacetic acid; 5-HT; serotonin; 6-OHDA; 6-hydroxydopamine; AIMs; Abnormal involuntary movements; ARC; activity-regulated cytoskeletal-associated protein; DA; dopamine; DOPAC; 3,4-dihydroxyphenylacetic acid; EDTA; ethylenediaminetetraac
Keywords: Essential tremor; Brain; Genetics; Human population; Mouse models; Pathophysiology; ABA; Allen brain atlas; AβPPswe/PS1ÎE9; amyloid-β protein precursor and presenilin-1; AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; ATP; adenosine tri-ph
Keywords: A/C; air-conditioning; BMP; best management practice; BUR; built-up bituminous roofing; CO2; carbon dioxide; CSO; combined sewer overflow; GHG; greenhouse gas; GSA; General Services Administration; LBNL; Lawrence Berkeley National Laboratory; LCCA; life-c
Keywords: IGF-1; insulin-like growth factor-1; LID; liver IGF-1 deficiency; WT; wild type; FFA; free fatty acid; 3-MA; 3-methyladenine; GH; growth hormone; mTOR; mammalian target of rapamycin; DMEM; Dulbecco's modified Eagle's medium; FBS; fetal bovine serum; P
Keywords: Biofilter; Bioretention system; Low impact development; LID; Lumbricidae; WSUD
In-situ characterization of electron-assisted regeneration of Cz-Si solar cells
Keywords: Solar cell; LID; Czochralski-grown silicon; Boron-oxygen defect; Regeneration;
Light and elevated temperature induced degradation in p-type and n-type cast-grown multicrystalline and mono-like silicon
Keywords: LID; LeTID; Degradation; Regeneration; Multicrystalline silicon; Mono-like silicon;
Selegiline increases on time without exacerbation of dyskinesia in 6-hydroxydopamine-lesioned rats displaying l-Dopa-induced wearing-off and abnormal involuntary movements
Keywords: 6-OHDA; 6-hydroxydopamine; AIMs; abnormal involuntary movements; ALO; axial, forelimb and orolingual; ANOVA; analysis of variance; Arc; activity-regulated cytoskeleton-associated protein; CDS; continuous dopaminergic stimulation; COMT; catechol-O-methyltr
Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: Implications for L-DOPA-induced dyskinesia
Keywords: Parkinson's disease; L-DOPA-Induced dyskinesia; Abnormal involuntary movements; D1R-D3R interactions; DA; Dopamine; DOPAC; Dihydroxyphenylacetic acid; PD; Parkinson's disease; LID; L-DOPA-Induced Dyskinesia; D1R; Dopamine D1 Receptor; D2R; Dopamine D2 Rec
Effect-based trigger values for in vitro and in vivo bioassays performed on surface water extracts supporting the environmental quality standards (EQS) of the European Water Framework Directive
Keywords: AA-EQS; average annual environmental quality standard; ACR; acute-to-chronic ratio; AhR; arylhydrocarbon receptor; AR; androgen receptor; AWTP; advanced water treatment plant; BEQ; bioanalytical equivalent concentration; DWTP; drinking water treatment pla
Understanding domain movements and interactions of Pseudomonas aeruginosa lipase with lipid molecule tristearoyl glycerol: A molecular dynamics approach
Keywords: Pseudomonas aeruginosa lipase; Molecular dynamics simulation; Lipid lipase interaction; Lid; GROMACS;
mGlu4 allosteric modulation for treating Parkinson's disease
Keywords: Parkinson's disease; Dyskinesia; Glutamate; Dopamine; mGlu4; 6-OHDA; 6-hydroxydopamine; ADX88178; 4-methyl-N-[5-methyl-4-(1H-pyrazol-4-yl)-1,3-thiazol-2-yl]pyrimidin-2-amine; AIM; abnormal involuntary movements; CODA-RET; complemented donor acceptor reson
Light induced degradation: kinetic model and grain boundary impact on sponge-LID
Keywords: silicon solar cells; degradation; LID; sponge-LID; multucrystalline silicon; high performance multi; degradation kinetics;
A preclinical study on the combined effects of repeated eltoprazine and preladenant treatment for alleviating L-DOPA-induced dyskinesia in Parkinson's disease
Keywords: 5-HT; Serotoninergic; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NHP; Non-human primate; PD; Parkinson's disease; LID; L-DOPA-induced dyskinesia; L-DOPA; L-3,4-dihydroxyphenylalanine; Parkinson's disease; L-DOPA-induced dyskinesia; 5-HT; Adenosin
Human COMT over-expression confers a heightened susceptibility to dyskinesia in mice
Keywords: BAC; bacterial artificial chromosome; COMT; catechol-O-methyltransferase; DA; dopamine; DOPAC; 3,4-dihydroxyphenylacetic acid; D1R; dopamine receptor 1; H3; histone 3; HPLC; high performance liquid chromatography; l-DOPA; l-3,4-dihydroxyphenylalanine; LID
On the meaning(fullness) of the intensity unit 'suns' in light induced degradation experiments
Keywords: light induced degradation; LID; silicon;
Region-specific bioconversion of dynorphin neuropeptide detected by in situ histochemistry and MALDI imaging mass spectrometry
Keywords: IMS; imaging mass spectrometry; DA; dopamine; PD; Parkinson's disease; LID; L-DOPA-induced dyskinesia; NEM; N-Ethylmaleimide; DynB; dynorphin B; Neuropeptide; Dynorphin; Bioconversion; Enzyme; Enzyme inhibitor; Histochemistry; MALDI imaging mass spectro
Mass production of p-type Cz silicon solar cells approaching average stable conversion efficiencies of 22 %
Keywords: Q.ANTUM; PERC; p-type; Cz; LID; LeTID;
Research PaperBDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to l-DOPA-induced dyskinesia in 6-OHDA-lesioned rats
Keywords: 6-OHDA; BDNF; Dyskinesia; SERT; LID; Parkinson's disease; Serotonin;
Effect of low-temperature annealing on defect causing copper-related light-induced degradation in p-type silicon
Keywords: silicon; LID; Cu; recovery; precipitate;
Daily consumption of methylene blue reduces attentional deficits and dopamine reduction in a 6-OHDA model of Parkinson's disease
Keywords: LID; l-dopa-induced dyskinesia; MB; methylene blue; NHS; normal horse serum; PB; phosphate buffer; PBS; phosphate-buffered saline; PD; Parkinson's disease; PFA; paraformaldehyde; SNc; substantia nigra; TH; tyrosine hydroxylase; VTA; ventral tegmental ar
Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia
Keywords: A2AR; Adenosine 2A receptor; AIM; abnormal involuntary movement; ANOVA; analysis of variance; BPND; non-displaceable binding potential; CNS; central nervous system; D2R; dopamine type 2 receptor; L-DOPA; levodopa; LID; levodopa-induced dyskinesia; MRTM; I
Research PaperCharacterizing the differential roles of striatal 5-HT1A auto- and hetero-receptors in the reduction of l-DOPA-induced dyskinesia
Keywords: LID; Serotonin 1A receptor; Biased agonist; Serotonin syndrome; Striatum; Parkinson's disease; Microinjection; Neuropharmacology;
Intrastriatal injection of ionomycin profoundly changes motor response to l-DOPA and its underlying molecular mechanisms
Keywords: AIMs; abnormal involuntary movement scale; ANOVA; analysis of variance; CPU; striatum; CREB; cAMP response element-binding protein; DARPP32; dopamine- and c-AMP-regulated phosphoprotein of 32Â kDa; DREAM; calcium-binding protein downstream regulatory elem